Crossject expands executive board to five with Lacombe, Morin, Seltz appointments
Bitget2026/09/25 05:30- Crossject expanded its Executive Board to five members, appointing Olivier Lacombe, Didier Morin, Lionel Seltz with immediate effect.
- Lacombe joined in 2021, bringing 21 years in pharmaceutical development from Fournier, Abbott, Solvay, Inventiva.
- Morin joined in 2023, bringing 30 years in industrial operations from IDS, Axess Vision.
- Seltz joined in January 2026, bringing 25 years in life sciences finance from Cegedim, IQVIA/IMS Health, Mars Group.
- Crossject US appointed David Pudwill as VP, Regulatory & Scientific Affairs; he brings about 20 years’ experience, including nine at the FDA.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pi Network News: PI Price Jumps 4% as Team Announces Three-Day Developer Summit
These Alts Bleed the Most as Bitcoin (BTC) Settles Below $82K: Weekend Watch
New York Fed warns: Service sector input and sales prices surge, significant price pressure
A survey by the New York Federal Reserve shows that service sector input costs and prices in October rose sharply, while the business activity index fell to its lowest level since March. Businesses have turned pessimistic about the outlook, with increasing inflation and interest rate pressures.
Crypto prices
More
